How to Get a Prescription for Priligy

"Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction". "Dapoxetine-A Novel Drug for Premature Ejaculation".

• Priligy helps improve control over ejaculation.
• It is generally well-tolerated with few side effects.
• Patients should avoid driving after use.
• Overdose can cause serious health issues.
• Use only as directed by your healthcare provider.
• Priligy is not recommended for women.
• It's effective for rapid ejaculation lasting less than 1 minute.
• The medication can be part of a broader treatment plan.
• Regular medical check-ups are advised during use.

"Dapoxetine for the treatment of premature ejaculation: Lack of interaction with ethanol".

• Priligy is the brand name for dapoxetine.
• It is used to treat premature ejaculation.
• Dapoxetine is a selective serotonin reuptake inhibitor.
• The medication is taken 1 to 3 hours before sex.
• Common side effects include nausea and dizziness.
• Priligy is approved in many countries for PE.
• Do not take with alcohol or CYP inhibiting meds.
• Consult a doctor before starting Priligy.
• It is available in 30 mg and 60 mg doses.

"Monoaminergic transporter binding and inhibition profile of dapoxetine, a medication for the treatment of premature ejaculation".

Medicine Overview of Dapoxen 30mg Tablet

"Cardiovascular safety profile of dapoxetine during the premarketing evaluation". "Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports". "Selective serotonin reuptake inhibitor discontinuation syndrome: a review". "Emerging treatments for premature ejaculation: focus on dapoxetine". "Dapoxetine: a novel treatment for premature ejaculation".

Premature ejaculation

"Stereoselective synthesis of (S)-dapoxetine starting from priligy 30mg buy online trans-cinnamyl alcohol". "Medical Non-Endocrine-Targeted Therapies: Ejaculatory Dysfunction and Immunotherapy". Diseases Companies Products Productz Mechanisms of Action Sites Priligy (dapoxetine) / AbbVie Welcome, Profile Billing Logout 6 Diseases 18 Trials 18 Trials 208 News 1 2 3 4 » Priligy (dapoxetine) / AbbVie Journal: Combined chiral-achiral supercritical fluid chromatography method for the impurity analysis of dapoxetine reveals insights in entropy-driven retention and acid-modulated selectivity. (Pubmed Central) - Dec 4, 2025 The neutral complexes impact retention depending on the amine substitution pattern and may suppress polar and enhance hydrophobic interactions. These results underscore the potential application of combined additive systems to enhance SFC applications in the field of ionizable analytes. "Physiology of ejaculation: emphasis on serotonergic control". "Supraspinal site of action for the inhibition of ejaculatory reflex by dapoxetine". "Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials". ^ "Dapoxetine: a guide to its use in premature ejaculation". "Pharmacokinetics of single and multiple escalating doses of dapoxetine in healthy volunteers". "Cardiovascular safety profile of dapoxetine during the premarketing evaluation". "Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports". "Selective serotonin reuptake inhibitor discontinuation syndrome: a review". "Emerging treatments for premature ejaculation: focus on dapoxetine". "Dapoxetine: a novel treatment for premature ejaculation". "Stereoselective synthesis of (S)-dapoxetine starting from priligy 30mg buy online trans-cinnamyl alcohol".

"Medical Non-Endocrine-Targeted Therapies: Ejaculatory Dysfunction and Immunotherapy".

Diseases Companies Products Productz Mechanisms of Action Sites Priligy (dapoxetine) / AbbVie Welcome, Profile Billing Logout 6 Diseases 18 Trials 18 Trials 208 News 1 2 3 4 » Priligy (dapoxetine) / AbbVie Journal: Combined chiral-achiral supercritical fluid chromatography method for the impurity analysis of dapoxetine reveals insights in entropy-driven retention and acid-modulated selectivity.

(Pubmed Central) - Dec 4, 2025 The neutral complexes impact retention depending on the amine substitution pattern and may suppress polar and enhance hydrophobic interactions. These results underscore the potential application of combined additive systems to enhance SFC applications in the field of ionizable analytes. Priligy (dapoxetine) / AbbVie Retrospective data, Journal: Dapoxetine combined with non-pharmacological approaches for lifelong premature ejaculation. (Pubmed Central) - Nov 12, 2025 Combination therapy increases IELT, reduces PEDT scores, and improves PEP scores. These findings suggest that combination therapy is more effective than dapoxetine monotherapy in improving functional outcomes and self-perception in patients with LPE, supported by moderate certainty of evidence. , Priligy (dapoxetine) / AbbVie Journal: Enantiodivergent Rh-Catalyzed Reductive Hydroformylation of Alkenyl Boronic Esters. (Pubmed Central) - Nov 11, 2025 DFT calculation has revealed the origin of enantiodivergence of Rh-catalyzed reductive AHF of alkenyl boronic esters with Ph-BPE as the chiral ligand. The transformation is promised to provide great synthetic potential in both academia and industry. Priligy (dapoxetine) / AbbVie Preclinical, Journal: Frequency-Dependent Effects of Repetitive Transcranial Magnetic Stimulation on Sexual Behavior Parameters in Premature Ejaculation Rodent Models. (Pubmed Central) - Nov 8, 2025 rTMS exhibited frequency-dependent therapeutic efficacy in rapid ejaculation rat models, with high-frequency protocols demonstrating superior benefits compared with low-frequency interventions. These effects are mediated through activation of the BDNF-TrkB pathway and enhanced serotonergic signaling, suggesting high-frequency rTMS as a promising non-pharmacological therapy for PE.

Frequently Questions & Answers

This pilot study suggests that the cognitive-behavioral therapy program supported by the male masturbation device may offer potential benefits for managing PE, but further research with larger samples is needed to confirm these preliminary findings. Journal: Efficacy and safety of pharmacological treatments in patients with premature ejaculation: an umbrella review of meta-analyses of randomized controlled trials. (Pubmed Central) - May 6, 2025 However, substantial heterogeneity among meta-analyses may limit the robustness of these findings. Priligy (dapoxetine) / AbbVie New trial: Study on the efficacy and safety of rTMS combined with dapoxetine hydrochloride in the treatment of premature ejaculation (EUDRACT) - Oct 30, 2025 P=N/A , N=90, Not yet recruiting, Sponsor: The First Affiliated Hospital of Anhui Medical University; The First Affiliated Hospital of Anhui Medical University Priligy (dapoxetine) / AbbVie Journal: The Inaugural Pre-Treatment Nomogram to Assess the Eight-Week Efficacy of Dapoxetine: A Prospective Multi-Center Study. (Pubmed Central) - Oct 9, 2025 In outpatient settings, it will enable andrologists to more accurately evaluate the efficacy and promptly adjust treatment plans for patients with scores below 153.4. Moreover, It will help patients who've taken dapoxetine for 4 Priligy (dapoxetine) / AbbVie Clinical, Retrospective data, Review, Journal, Monotherapy: Efficacy and safety of on-demand dapoxetine combined with phosphodiesterase-5 inhibitor compared to monotherapy dapoxetine as a treatment of premature ejaculation without erectile dysfunction: a (Pubmed Central) - Oct 1, 2025 This study demonstrates that the combination of dapoxetine and PDE-5i significantly improves post-treatment scores of IELT and sexual satisfaction compared to dapoxetine monotherapy. Despite an increased risk of certain side effects, the overall tolerability of the combination therapy remains favorable. Priligy (dapoxetine) / AbbVie PK/PD data, Journal: priligy 15 mg Population Pharmacokinetics of Dapoxetine in Healthy Chinese Male Subjects. (Pubmed Central) - Oct 1, 2025 The CYP3A4*1G allele influenced Q/F, while body mass index (BMI) was a significant covariate on Vc/F. Our analysis identified CYP2D6*10 and CYP2D6*41 polymorphisms as the significant factors contributing to inter-individual variability and influencing drug exposure.

Full Consumer Medicine Information (CMI)

Priligy (dapoxetine) / AbbVie New P4 trial: Comparative Evaluation of Safety and Efficacy of Dapoxetine, Silodosin, and Citalopram in the Management of Premature Ejaculation (clinicaltrials.gov) - Aug 18, 2025 P4 , N=450, Completed, Sponsor: Beni-Suef University Priligy (dapoxetine) / AbbVie , paroxetine / Generic mfg. And the patients obviously preferred the former to the latter, which might be partly attributed to the higher price of dapoxetine. Priligy (dapoxetine) / AbbVie New P2/3 trial: On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation (clinicaltrials.gov) - Jul 25, 2025 P2/3 , N=95, Completed, Sponsor: Benha University Priligy (dapoxetine) / AbbVie Journal: Uncovering novel therapeutic targets for premature ejaculation from gut microbiota: A prospective high-throughput sequencing study. (Pubmed Central) - Jul 22, 2025 This study identified gut microbiota associated with the efficacy of dapoxetine for the first time. Targeted modulation of specific gut microbiota may provide a novel strategy for PE treatment.

Vardenafil Combination Products

Priligy (dapoxetine) / AbbVie New trial: Comparison of the Efficacy and Safety of Dapoxetine, Kegel Exercises, and Acupuncture in the Treatment of Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled Trial (clinicaltrials.gov) - Jul 16, 2025 P=N/A , N=250, Not yet recruiting, Sponsor: Medipol University Priligy (dapoxetine) / AbbVie Journal: Management and treatment variations in premature ejaculation: a nationwide survey by the Andrology Working Group of the Society of Urological Surgery in Turkey. (Pubmed Central) - Jun 6, 2025 This study revealed substantial variability in PE management, its multifaceted etiology and guideline limitations. The findings underscore the need for standardized, evidence-based protocols to enhance clinical outcomes and optimize patient satisfaction. Priligy (dapoxetine) / AbbVie New P1 trial: A prospective clinical study of progressive penile root behavior training and Dapoxetine hydrochloride in the treatment of premature ejaculation (EUDRACT) - Jun 5, 2025 P1 , N=468, Not yet recruiting, Sponsor: Affiliated Panyu Central Hospital of Guangzhou Medical University; Affiliated Panyu Central Hospital of Guangzhou Medical University Priligy (dapoxetine) / AbbVie Journal: A prospective and comparative evaluation of a male masturbation device for premature ejaculation-functional outcomes, safety, and satisfaction assessment: a pilot study. (Pubmed Central) - May 23, 2025 The findings underscore the need for standardized, evidence-based protocols to enhance clinical outcomes and optimize patient satisfaction. Priligy (dapoxetine) / AbbVie Clinical, Journal: Clinical research of Zhuangdan Yanshi Decoction combined with dapoxetine hydrochloride in the treatment of premature ejaculation with cholestasis and phlegm disturbance syndrome (Pubmed Central) - Sep 5, 2025 Our analysis identified CYP2D6*10 and CYP2D6*41 polymorphisms as the significant factors contributing to inter-individual variability and influencing drug exposure. The combination therapy with Zhuangdan Yanshi Decoction and dapoxetine hydrochloride for premature ejaculation associated with cholestasis and phlegm disturbance syndrome is definite, and it can reduce the side effects of drugs, which is better than oral dapoxetine hydrochloride alone. Journal: Causal association between erectile dysfunction and the risk of myocardial infarction: A two-sample bidirectional Mendelian randomization study (Pubmed Central) - Sep 5, 2025 The combination therapy with Zhuangdan Yanshi Decoction and dapoxetine hydrochloride for premature ejaculation associated with cholestasis and phlegm disturbance syndrome is definite, and it can reduce the side effects of drugs, which is better than oral dapoxetine hydrochloride alone. There is a causal relationship between ED and MI, with smoking as a potential mediating factor, and the gene PTPN11 being a co-target gene. Priligy (dapoxetine) / AbbVie New P4 trial: Comparative Evaluation of Safety and Efficacy of Dapoxetine, Silodosin, and Citalopram in the Management of Premature Ejaculation (clinicaltrials.gov) - Aug 18, 2025 P4 , N=450, Completed, Sponsor: Beni-Suef University Priligy (dapoxetine) / AbbVie , paroxetine / Generic mfg.

Some other brands of Dapoxetine :

Priligy (dapoxetine) / AbbVie Retrospective data, Journal: Dapoxetine combined with non-pharmacological approaches for lifelong premature ejaculation. (Pubmed Central) - Nov 12, 2025 Combination therapy increases IELT, reduces PEDT scores, and improves PEP scores. These findings suggest that combination therapy is more effective than dapoxetine monotherapy in improving functional outcomes and self-perception in patients with LPE, supported by moderate certainty of evidence. , Priligy (dapoxetine) / AbbVie Journal: Enantiodivergent Rh-Catalyzed Reductive Hydroformylation of Alkenyl Boronic Esters. (Pubmed Central) - Nov 11, 2025 DFT calculation has revealed the origin of enantiodivergence of Rh-catalyzed reductive AHF of alkenyl boronic esters with Ph-BPE as the chiral ligand.

Loyalty Rewards

The transformation is promised to provide great synthetic potential in both academia and industry. Priligy (dapoxetine) / AbbVie Preclinical, Journal: Frequency-Dependent Effects of Repetitive Transcranial Magnetic Stimulation on Sexual Behavior Parameters in Premature Ejaculation Rodent Models. (Pubmed Central) - Nov 8, 2025 rTMS exhibited frequency-dependent therapeutic efficacy in rapid ejaculation rat models, with high-frequency protocols demonstrating superior benefits compared with low-frequency interventions. These effects are mediated through activation of the BDNF-TrkB pathway and enhanced serotonergic signaling, suggesting high-frequency rTMS as a promising non-pharmacological therapy for PE. Priligy (dapoxetine) / AbbVie New trial: Study on the efficacy and safety of rTMS combined with dapoxetine hydrochloride in the treatment of premature ejaculation (EUDRACT) - Oct 30, 2025 P=N/A , N=90, Not yet recruiting, Sponsor: The First Affiliated Hospital of Anhui Medical University; The First Affiliated Hospital of Anhui Medical University Priligy (dapoxetine) / AbbVie Journal: The Inaugural Pre-Treatment Nomogram to Assess the Eight-Week Efficacy of Dapoxetine: A Prospective Multi-Center Study. And the patients obviously preferred the former to the latter, which might be partly attributed to the higher price of dapoxetine. Priligy (dapoxetine) / AbbVie New P2/3 trial: On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation (clinicaltrials.gov) - Jul 25, 2025 P2/3 , N=95, Completed, Sponsor: Benha University Priligy (dapoxetine) / AbbVie Journal: Uncovering novel therapeutic targets for premature ejaculation from gut microbiota: A prospective high-throughput sequencing study.

Adverse effects

(Pubmed Central) - Oct 9, 2025 In outpatient settings, it will enable andrologists to more accurately evaluate the efficacy and promptly adjust treatment plans for patients with scores below 153.4. Moreover, It will help patients who've taken dapoxetine for 4 Priligy (dapoxetine) / AbbVie Clinical, Retrospective data, Review, Journal, Monotherapy: Efficacy and safety of on-demand dapoxetine combined with phosphodiesterase-5 inhibitor compared to monotherapy dapoxetine as a treatment of premature ejaculation without erectile dysfunction: a (Pubmed Central) - Oct 1, 2025 This study demonstrates that the combination of dapoxetine and PDE-5i significantly improves post-treatment scores of IELT and sexual satisfaction compared to dapoxetine monotherapy. Despite an increased risk of certain side effects, the overall tolerability of the combination therapy remains favorable. Priligy (dapoxetine) / AbbVie PK/PD data, Journal: priligy 15 mg Population Pharmacokinetics of Dapoxetine in Healthy Chinese Male Subjects. (Pubmed Central) - Oct 1, 2025 The CYP3A4*1G allele influenced Q/F, while body mass index (BMI) was a significant covariate on Vc/F.

Depression and anxiety

Our analysis identified CYP2D6*10 and CYP2D6*41 polymorphisms as the significant factors contributing to inter-individual variability and influencing drug exposure. Priligy (dapoxetine) / AbbVie Clinical, Journal: Clinical research of Zhuangdan Yanshi Decoction combined with dapoxetine hydrochloride in the treatment of premature ejaculation with cholestasis and phlegm disturbance syndrome (Pubmed Central) - Sep 5, 2025 Our analysis identified CYP2D6*10 and CYP2D6*41 polymorphisms as the significant factors contributing to inter-individual variability and influencing drug exposure. The combination therapy with Zhuangdan Yanshi Decoction and dapoxetine hydrochloride for premature ejaculation associated with cholestasis and phlegm disturbance syndrome is definite, and it can reduce the side effects of drugs, which is better than oral dapoxetine hydrochloride alone. Journal: Causal association between erectile dysfunction and the risk of myocardial infarction: A two-sample bidirectional Mendelian randomization study (Pubmed Central) - Sep 5, 2025 The combination therapy with Zhuangdan Yanshi Decoction and dapoxetine hydrochloride for premature ejaculation associated with cholestasis and phlegm disturbance syndrome is definite, and it can reduce the side effects of drugs, which is better than oral dapoxetine hydrochloride alone. There is a causal relationship between ED and MI, with smoking as a potential mediating factor, and the gene PTPN11 being a co-target gene. (Pubmed Central) - Jul 22, 2025 This study identified gut microbiota associated with the efficacy of dapoxetine for the first time.

Combination Ingredients for Men’s Sexual Health

"Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction". "Dapoxetine-A Novel Drug for Premature Ejaculation". "Dapoxetine for the treatment of premature ejaculation: Lack of interaction with ethanol". "Monoaminergic transporter binding and inhibition profile of dapoxetine, a medication for the treatment of premature ejaculation".

Who distributes PRILIGY

"Physiology of ejaculation: emphasis on serotonergic control". "Supraspinal site of action for the inhibition of ejaculatory reflex by dapoxetine". "Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials". ^ "Dapoxetine: a guide to its use in premature ejaculation". "Pharmacokinetics of single and multiple escalating doses of dapoxetine in healthy volunteers". Targeted modulation of specific gut microbiota may provide a novel strategy for PE treatment. Priligy (dapoxetine) / AbbVie New trial: Comparison of the Efficacy and Safety of Dapoxetine, Kegel Exercises, and Acupuncture in the Treatment of Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled Trial (clinicaltrials.gov) - Jul 16, 2025 P=N/A , N=250, Not yet recruiting, Sponsor: Medipol University Priligy (dapoxetine) / AbbVie Journal: Management and treatment variations in premature ejaculation: a nationwide survey by the Andrology Working Group of the Society of Urological Surgery in Turkey. (Pubmed Central) - Jun 6, 2025 This study revealed substantial variability in PE management, its multifaceted etiology and guideline limitations. The findings underscore the need for standardized, evidence-based protocols to enhance clinical outcomes and optimize patient satisfaction. Priligy (dapoxetine) / AbbVie New P1 trial: A prospective clinical study of progressive penile root behavior training and Dapoxetine hydrochloride in the treatment of premature ejaculation (EUDRACT) - Jun 5, 2025 P1 , N=468, Not yet recruiting, Sponsor: Affiliated Panyu Central Hospital of Guangzhou Medical University; Affiliated Panyu Central Hospital of Guangzhou Medical University Priligy (dapoxetine) / AbbVie Journal: A prospective and comparative evaluation of a male masturbation device for premature ejaculation-functional outcomes, safety, and satisfaction assessment: a pilot study. (Pubmed Central) - May 23, 2025 The findings underscore the need for standardized, evidence-based protocols to enhance clinical outcomes and optimize patient satisfaction. This pilot study suggests that the cognitive-behavioral therapy program supported by the male masturbation device may offer potential benefits for managing PE, but further research with larger samples is needed to confirm these preliminary findings. Journal: Efficacy and safety of pharmacological treatments in patients with premature ejaculation: an umbrella review of meta-analyses of randomized controlled trials. (Pubmed Central) - May 6, 2025 However, substantial heterogeneity among meta-analyses may limit the robustness of these findings.